{"id":"W4400143742","doi":"10.1016/j.annonc.2024.05.055","title":"44P BOLD-100-001: A phase II study of BOLD-100 in combination with FOLFOX in advanced mCRC patients that have failed at least two prior lines of therapy","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Translational Research in Oncology; iCo Therapeutics (Canada); Innovative Targeting Solutions (Canada); McGill University; Princess Margaret Cancer Centre; University Health Network; Jewish General Hospital; McMaster University; Ottawa Regional Cancer Foundation; Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; FOLFOX; Internal medicine; Oncology; Phases of clinical research; Oxaliplatin; Colorectal cancer; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006415649,0.0001735766,0.0007882059,0.0004547607,0.0000300973,0.000004290585,0.0001298234,0.00009152344,0.00005024812],"category_scores_gemma":[0.0002022049,0.0001316908,0.00006665666,0.0003372271,0.0001543157,0.0001063147,0.00007290696,0.0003399725,0.00000107112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007163882,"about_ca_system_score_gemma":0.0001541755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005133716,"about_ca_topic_score_gemma":0.0004768974,"domain_scores_codex":[0.9982634,0.0001830714,0.0006409952,0.0003094634,0.0003533009,0.0002497785],"domain_scores_gemma":[0.9989159,0.0002457479,0.0003156594,0.0002194023,0.0002260371,0.00007731427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005509324,0.03094815,0.4012728,0.000303241,0.0002434754,0.0002011039,0.0102051,0.0003246914,0.009157815,0.00009249267,0.0006155021,0.5411263],"study_design_scores_gemma":[0.1876784,0.2172808,0.5251937,0.002672169,0.0002376852,0.00004048869,0.00508062,0.02336417,0.01963377,0.000480034,0.01771509,0.0006231062],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949653,0.0007514267,0.00002647608,0.002605815,0.0001599317,0.001006111,0.000008266609,0.00001810992,0.0004586032],"genre_scores_gemma":[0.9987083,0.0003542772,0.0002324164,0.0003687774,0.00003293546,0.00005172077,0.00004271427,0.00002858563,0.0001802526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5405031,"threshold_uncertainty_score":0.5370195,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05152543002927577,"score_gpt":0.4220904643900035,"score_spread":0.3705650343607277,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}